Tyra Biosciences, Inc

This study is testing an oral drug called TYRA-300 in children aged 3 to 10 with achondroplasia, the most common form of dwarfism. The main goals are to see if the drug is safe and to find the right dose that might help children grow faster. Researchers will measure changes in th…

This study is testing an oral drug called dabogratinib (TYRA-300) for adults with a specific type of low-grade cancer in the upper urinary tract. The main goal is to see if the drug can completely eliminate the tumors, potentially allowing patients to avoid major kidney-removal s…

This is the first study in people testing an experimental pill called TYRA-430. It aims to find a safe dose and see if it can help control advanced liver cancer and other solid tumors that have specific genetic changes in the FGF/FGFR pathway. The study will enroll about 100 adul…

This study is testing an oral medication called TYRA-300 for adults with early-stage, non-muscle-invasive bladder cancer that has a specific genetic change (FGFR3). The goal is to see if the pill can completely eliminate visible tumors left in the bladder after a biopsy. Research…